COMMUNIQUÉS West-GlobeNewswire

Vaxcyte to Present at the 2024 Cantor Global Healthcare Conference

11/09/2024 - 22:05

SAN CARLOS, Calif., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial [...]

Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference

11/09/2024 - 22:05

IRVINE, Calif., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer, will participate in a fireside chat [...]

Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares

11/09/2024 - 22:04

BOSTON and LONDON, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for [...]

UPDATE - Glass House Brands to Host Analyst & Institutional Investor Day on September 12, 2024 at the SoCal Farm in Camarillo, California

11/09/2024 - 20:48

LONG BEACH, Calif. and TORONTO, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Glass House Brands Inc. (“Glass House” or the “Company”) (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF), one of the fastest- [...]

IGI annonce la publication d’un article dans Nature Cancer sur l’ISB 2001, l’anticorps tri-spécifique novateur d’IGI pour le traitement du myélome multiple en rechute ou réfractaire

11/09/2024 - 20:17

L’article met en évidence les résultats précliniques démontrant que l’ISB 2001 peut potentiellement déjouer les mécanismes d’échappement des cellules myélomateuses pour contourner l’activité thérapeutique antitumorale [...]

Dean Schauer Appointed Chairman of the Board of Confluent Medical Technologies

11/09/2024 - 19:34

SCOTTSDALE, Ariz., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Confluent Medical Technologies (Confluent) announced today that Dean Schauer, who has served as the company’s Chief Executive Officer for more than a decade, has [...]

BriaCell Therapeutics Announces $8.5 Million Offering

11/09/2024 - 18:09

Priced At-the-Market Under Nasdaq Rules PHILADELPHIA and VANCOUVER, British Columbia, Sept. 11, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a [...]

ORYZON Receives “Intention to Grant” Communication for Patent Relating to the Use of Vafidemstat in Borderline Personality Disorder

11/09/2024 - 18:07

From the European Patent Office MADRID and CAMBRIDGE, Mass., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to [...]

BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production

11/09/2024 - 17:05

KUALA LUMPUR, Malaysia, Sept. 11, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp (Nasdaq: BGLC, the “Company”), an emerging Biotech & Chemicals company, is pleased to announce that its subsidiary, Chemrex [...]

Ultimovacs Announces Patient Recruitment Discontinuation in LUNGVAC Trial Investigating UV1 Combined with Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer

11/09/2024 - 17:00

Oslo, September 11, 2024: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing immunotherapeutic cancer vaccines, today announced that the company has agreed with the investigators [...]

InBrain Pharma announces the publication of an article on the pharmacokinetic and pharmacodynamic limitations of L-DOPA in the management of Parkinson's disease in the Journal of Parkinson's Disease

11/09/2024 - 16:30

InBrain Pharma announces the publication of an article on the pharmacokinetic and pharmacodynamic limitations of L-DOPA in the management of Parkinson's disease in the Journal of Parkinson's Disease Lille, September 11 [...]

KFSHRC Announced a Strategic Partner for 2024 NYC C3 Summit Davos of Healthcare

11/09/2024 - 16:16

RIYADH, Saudi Arabia, Sept. 11, 2024 (GLOBE NEWSWIRE) -- In a significant move to bolster its global presence, the King Faisal Specialist Hospital & Research Centre (KFSHRC) is set to join as a key partner in the [...]

Merit Medical to Present at the 2024 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Congress

11/09/2024 - 15:25

SOUTH JORDAN, Utah, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that clinicians will present [...]

RenovaroCube Announces Strategic Offering of Up to 20% Ownership

11/09/2024 - 15:15

AMSTERDAM, Sept. 11, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RENB) The Board of Renovaro, Inc (RENB) intends to seek strategic investors to acquire up to 20% of RenovaroCube (Cube), currently a wholly owned subsidiary. This [...]

PacBio Announces the HiFi Solves Sub-fertility Consortium in Asia Pacific

11/09/2024 - 15:05

Collaboration Aims to Harness HiFi Sequencing to Improve Diagnosis and Treatment of Subfertility and Recurrent Pregnancy Loss SINGAPORE, Sept. 11, 2024 (GLOBE NEWSWIRE) -- The HiFi Solves Sub-fertility Consortium, an [...]

AIM ImmunoTech Announces that Analysis of AMP-518 Complete Clinical Patient Data Underscores Ampligen’s Potential to Improve the Post-COVID Condition of Fatigue

11/09/2024 - 15:00

Company is planning a follow-up clinical trial with a focused subject population of moderate-to-severe Post-COVID-related fatigue OCALA, Fla., Sept. 11, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM [...]

Conception Nurseries Publishes White Paper Detailing Industry Saving Methods for Using Tissue Culture to Prevent Diseases in Cannabis Cultivation

11/09/2024 - 15:00

SACRAMENTO, Calif., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Conception Nurseries , the industry leading biotech company and single largest cannabis plant producer in the world, today published a white paper detailing the [...]

PharmAla to supply Johns Hopkins Medicine for Clinical Trial

11/09/2024 - 14:55

TORONTO, Sept. 11, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]

VPR Brands Continues Aggressive Patent Enforcement With New Infringement Cases and Strategic Efforts for Future Protection

11/09/2024 - 14:49

VPR Brands Aims to Drive the Next Wave of Growth in the Vaping Industry While Ensuring That Our Technologies Set the Standard for Quality and Innovation FORT LAUDERDALE, FL, Sept. 11, 2024 (GLOBE NEWSWIRE) -- VPR BRANDS [...]